Caligan Partners Lp - Net Worth and Insider Trading
Caligan Partners Lp Net Worth
The estimated net worth of Caligan Partners Lp is at least $196 Million dollars as of 2024-11-28. Caligan Partners Lp is the 10% Owner of Alimera Sciences Inc and owns about 16,835,154 shares of Alimera Sciences Inc (ALIM) stock worth over $93 Million. Caligan Partners Lp is the Director, 10% Owner of Liquidia Corp and owns about 7,015,356 shares of Liquidia Corp (LQDA) stock worth over $81 Million. Caligan Partners Lp is also the 10% Owner of Standard BioTools Inc and owns about 11,444,836 shares of Standard BioTools Inc (LAB) stock worth over $21 Million. Details can be seen in Caligan Partners Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Caligan Partners Lp has not made any transactions after 2024-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Caligan Partners Lp
Caligan Partners Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Caligan Partners Lp owns 5 companies in total, including AMAG Pharmaceuticals Inc (AMAG) , Standard BioTools Inc (LAB) , and Liquidia Corp (LQDA) among others .
Click here to see the complete history of Caligan Partners Lp’s form 4 insider trades.
Insider Ownership Summary of Caligan Partners Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AMAG | AMAG Pharmaceuticals Inc | 2019-08-12 | 10 percent owner |
| LAB | Standard BioTools Inc | 2022-08-04 | 10 percent owner |
| LQDA | Liquidia Corp | 2024-08-30 | director & 10 percent owner & other: See Remarks |
 | | 2023-05-31 | director & other: See Remarks |
| | 2023-09-14 | 10 percent owner |
Caligan Partners Lp Latest Holdings Summary
Caligan Partners Lp currently owns a total of 3 stocks. Among these stocks, Caligan Partners Lp owns 16,835,154 shares of Alimera Sciences Inc (ALIM) as of September 14, 2023, with a value of $93 Million and a weighting of 47.69%. Caligan Partners Lp owns 7,015,356 shares of Liquidia Corp (LQDA) as of August 30, 2024, with a value of $81 Million and a weighting of 41.66%. Caligan Partners Lp also owns 11,444,836 shares of Standard BioTools Inc (LAB) as of August 4, 2022, with a value of $21 Million and a weighting of 10.65%.
Latest Holdings of Caligan Partners Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALIM | Alimera Sciences Inc | 2023-09-14 | 16,835,154 | 5.54 | 93,266,753 |
| LQDA | Liquidia Corp | 2024-08-30 | 7,015,356 | 11.62 | 81,483,360 |
| LAB | Standard BioTools Inc | 2022-08-04 | 11,444,836 | 1.82 | 20,829,602 |
Holding Weightings of Caligan Partners Lp
Caligan Partners Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Caligan Partners Lp has made a total of 2 transactions in Alimera Sciences Inc (ALIM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Alimera Sciences Inc is the sale of 579,000 shares on September 14, 2023, which brought Caligan Partners Lp around $2 Million.
According to the SEC Form 4 filings, Caligan Partners Lp has made a total of 7 transactions in Liquidia Corp (LQDA) over the past 5 years, including 6 buys and 1 sells. The most-recent trade in Liquidia Corp is the sale of 150,000 shares on August 30, 2024, which brought Caligan Partners Lp around $1 Million.
According to the SEC Form 4 filings, Caligan Partners Lp has made a total of 8 transactions in Standard BioTools Inc (LAB) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Standard BioTools Inc is the acquisition of 301,182 shares on August 4, 2022, which cost Caligan Partners Lp around $527,068.
Insider Trading History of Caligan Partners Lp
- 1
Caligan Partners Lp Trading Performance
GuruFocus tracks the stock performance after each of Caligan Partners Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Caligan Partners Lp is -5.01%. GuruFocus also compares Caligan Partners Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Caligan Partners Lp within 3 months outperforms 4 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Caligan Partners Lp's insider trading performs compared to the benchmark.
Performance of Caligan Partners Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.51 | | | | | |
| Relative Return to S&P 500(%) | -3.59 | | | | | |
Caligan Partners Lp Ownership Network
Caligan Partners Lp Owned Company Details
What does AMAG Pharmaceuticals Inc do?
Who are the key executives at AMAG Pharmaceuticals Inc?
Caligan Partners Lp is the 10 percent owner of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .
AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.
AMAG Pharmaceuticals Inc Insider Transactions
Caligan Partners Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Caligan Partners Lp. You might contact Caligan Partners Lp via mailing address: 515 Madison Avenue, 8th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
